Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Dhampur Bio Organics Ltd ( (IN:DBOL) ) has provided an announcement.
Dhampur Bio Organics Ltd’s board has approved the company’s unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025, in compliance with SEBI’s listing regulations, and has released these results along with the auditors’ limited review report. The board also noted the execution of a non-binding term sheet with Switzerland-based Planetary SA to explore an exclusive arrangement for producing and commercializing mycoprotein in India using sugar and side streams as feedstock, signaling a potential strategic diversification into alternative protein and value-added bio-based products, subject to definitive agreements and regulatory disclosures.
More about Dhampur Bio Organics Ltd
Dhampur Bio Organics Ltd is an Indian company in the sugar and bio-organics sector, operating from industrial and sugar mill locations in Uttar Pradesh and New Delhi. The company focuses on processing sugar and related side streams, positioning itself within the broader bio-based products and agro-processing industry.
Average Trading Volume: 3,798
Technical Sentiment Signal: Sell
Current Market Cap: 5.12B INR
For detailed information about DBOL stock, go to TipRanks’ Stock Analysis page.